Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial.

Read more: https://www.birmingham.ac.uk/news/2025/adding-antibody-treatment-to-chemo-boosts-outcomes-for-children-with-rare-cancer